The SRC-3/AIB1 coactivator is degraded 14 in a ubiquitin- and ATP-independent manner by the REGγ proteasome

被引:222
作者
Li, XT
Lonard, DM
Jung, SY
Malovannaya, A
Feng, G
Qin, J
Tsai, SY
Tsai, MJ
O'Malley, BW
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
[2] Chongqing Univ Med Sci, Affiliated Hosp 1, Chongqing 400016, Peoples R China
关键词
D O I
10.1016/j.cell.2005.11.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Steroid receptor coactivator-3 (SRC-3/AIB1) is an oncogene frequently amplified and overexpressed in breast cancers. Here we report that SRC-3 interacts with REG gamma, a proteasome activator known to stimulate the trypsin-like activity of the 20S proteasome. RNAi knockdown and gain-of-function experiments suggest that REG gamma promotes SRC-3 protein degradation. Cellular levels of REG gamma expression affect estrogen-receptor target-gene expression and cell growth as a result of its ability to promote degradation of the SRC-3 protein. In vitro proteasome proteolysis assays using purified REGy, SRC-3, and the 20S proteasome reinforce these conclusions and demonstrate that REG gamma promotes the degradation of SRC-3 in a ubiquitin- and ATP-independent manner. This work demonstrates the first example of a physiologically relevant endogenous cellular target for the REG gamma-proteasome complex. It also highlights the fact that an alternative mode of proteasome-mediated protein degradation, independent of the 19S proteasome regulatory cap, targets the SRC-3 protein for degradation.
引用
收藏
页码:381 / 392
页数:12
相关论文
共 44 条
[1]   Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression [J].
Abba, MC ;
Drake, JA ;
Hawkins, KA ;
Hu, YH ;
Sun, HX ;
Notcovich, C ;
Gaddis, S ;
Sahin, A ;
Baggerly, K ;
Aldaz, CM .
BREAST CANCER RESEARCH, 2004, 6 (05) :R499-R513
[2]   AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer [J].
Anzick, SL ;
Kononen, J ;
Walker, RL ;
Azorsa, DO ;
Tanner, MM ;
Guan, XY ;
Sauter, G ;
Kallioniemi, OP ;
Trent, JM ;
Meltzer, PS .
SCIENCE, 1997, 277 (5328) :965-968
[3]   A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73 [J].
Asher, G ;
Tsvetkov, P ;
Kahana, C ;
Shaul, Y .
GENES & DEVELOPMENT, 2005, 19 (03) :316-321
[4]   A ratchet mechanism of transcription elongation and its control [J].
Bar-Nahum, G ;
Epshtein, V ;
Ruckenstein, AE ;
Rafikov, R ;
Mustaev, A ;
Nudler, E .
CELL, 2005, 120 (02) :183-193
[5]   Immune defects in 28-kDa proteasome activator γ-deficient mice [J].
Barton, LF ;
Runnels, HA ;
Schell, TD ;
Cho, YJ ;
Gibbons, R ;
Tevethia, SS ;
Deepe, GS ;
Monaco, JJ .
JOURNAL OF IMMUNOLOGY, 2004, 172 (06) :3948-3954
[6]  
Bautista S, 1998, CLIN CANCER RES, V4, P2925
[7]  
Bouras T, 2001, CANCER RES, V61, P903
[8]   ACCURATE TRANSCRIPTION INITIATION BY RNA POLYMERASE-II IN A SOLUBLE EXTRACT FROM ISOLATED MAMMALIAN NUCLEI [J].
DIGNAM, JD ;
LEBOVITZ, RM ;
ROEDER, RG .
NUCLEIC ACIDS RESEARCH, 1983, 11 (05) :1475-1489
[9]  
DUBIEL W, 1992, J BIOL CHEM, V267, P22369
[10]  
JUGN SY, 2005, J MOL ENDOCRINOL, V19, P2451